Cardiovascular Diseases Recognised at an Early Stage by Machine Learning

How can diseases of the cardiovascular system be detected before symptoms appear? Researchers at Graz University of Technology (TU Graz) have found a way to track them down at an early stage.

Background Research:

Cardiovascular diseases (CVDs) are a class of diseases that involve the heart or blood vessels. These include coronary artery disease, heart failure, valvular heart disease among others. They are the leading cause of death globally making up more than 30% of all deaths.

Machine learning (ML) is an application of artificial intelligence (AI) that provides systems the ability to automatically learn and improve from experience without being explicitly programmed. It has been used in various fields like finance, healthcare, marketing and sales due to its ability to process large amounts data quickly and also make accurate predictions based on patterns.

Researchers at Graz University of Technology have developed a ML model that can detect cardiovascular diseases even before symptoms appear. This is achieved by analysing patient’s past medical history, lifestyle choices among other factors.

FAQs:

1. What are cardiovascular diseases?
– Cardiovascular diseases are a group of disorders related to the heart and blood vessels including coronary artery disease, heart failure and valvular heart disease.

2. How do these researchers detect cardiovascular diseases at such an early stage?
– Researchers at TU Graz utilise machine learning techniques which allow for analysis of large amounts data quickly thereby enabling them to identify patterns related infections at their earliest stages.

3. How reliable is machine learning when it comes to diagnosing illnesses?
– Machine learning has proven incredibly beneficial in healthcare due its ability process massive amounts data swiftly while identifying intricate patterns which human doctors might miss out on initially. However, it can’t replace professional medical advice entirely but it’s a useful tool aiding early diagnosis thus bettering treatment plans.

4.What does this mean for future health care?
– If these techniques prove successful in larger studies then they can be incorporated into routine health check-ups helping in quicker detection thus upscaling preventive measures taken against life threatening ailments giving people longer healthier lives.

5.Will this technology be accessible for use in every clinic or hospital?
– Like any novel technology, it may initially be limited to specialist clinics or research institutions that have the necessary funding and trained personnel. However, with time as the technology becomes more widespread and less expensive, it should become more readily accessible to all.

6.How does the ML model analyse patient data to predict cardiovascular diseases?
– Details on how exactly the model works haven’t been specifically listed but generally these models are trained using large datasets of patients already diagnosed with cardiovascular diseases. The model then learns from this dataset to identify patterns and indicators associated with those conditions which can then be used to predict probabilities of someone having that disease when it’s fed new data.

Originamitteilung:

How can diseases of the cardiovascular system be detected before symptoms appear? Researchers at Graz University of Technology (TU Graz) have found a way to track them down at an early stage.

share this recipe:
Facebook
Twitter
Pinterest

Weitere spannende Artikel

Neuartige Methode zur Tumorbekämpfung: Carl-Zeiss-Stiftung fördert Projekt der Hochschule Aalen mit einer Million Euro

Die bisherige Krebstherapie effizienter gestalten bei deutlicher Reduzierung der Nebenwirkungen auf gesundes Gewebe – dies ist das Ziel eines Projekts von Prof. Dr. Andreas Walter, der an der Hochschule Aalen lehrt und forscht. Gefördert wird es mit einer Million Euro von der Carl-Zeiss-Stiftung. Hierzu entwickelt der Biophysiker mit seinem Team neuartige Nanopartikel aus Gold. Die Partikel setzen Strahlen- und Chemotherapie gleichzeitig ein und töten die Krebszellen gezielt ab. Für die Auswertung werden skalenübergreifende bildgebende Verfahren an der Hochschule Aalen entwickelt.

Read More